Bilaketaren emaitzak - Canan Alhan

Validation of the diagnostic potential of 17 immunophenotypic core markers defined by the ELN‐iMDS‐Flow Working Group in an independent cohort of patients with MDS nork Coen R. Veenstra, Canan Alhan, Theresia M. Westers, Arjan A. van deLoosdrecht

Testu osoa

Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study nork Matteo G. Della Porta, Cristina Picone, Cristiana Pascutto, Luca Malcovati, Hideto Tamura, Hiroshi Handa, Magdalena Czader, Sylvie Freeman, Paresh Vyas, Anna Porwit, Leonie Saft, Theresia M. Westers, Canan Alhan, Claudia Cali, Arjan A. van de Loosdrecht, Kiyoyuki Ogata

Testu osoa

Development of Machine‐Assisted, Human‐Centred Bone Marrow Cell Classification: Feasibility Analysis in Patients With Myelodysplastic Syndromes nork Kiyoyuki Ogata, Yuto Mochimaru, Leonie Saft, Gerrit Sijm, Bouchra Badaoui, Canan Alhan, Carole Almire, Yosuke Kato, Daisuke Sakamoto, Naoko Chiba, Naho Murata, Nana Kasai, Kazuma Sei, Naoya Kawahara, Mika Ogata, Nicolas Chapuis, Orianne Wagner‐Ballon, Arjan van deLoosdrecht, Yumi Yamamoto

Testu osoa

Expression levels of genes implicated in the working mechanism of lenalidomide predict treatment response in lower risk myelodysplastic syndrome patients nork Florentien E.M. in’t Hout, Thessa N. Scheele, Theresia M. Westers, Canan Alhan, Carolien Duetz, Eline M.P. Cremers, Heleen A. Visser-Wisselaar, Annelies Verbrugge, Dana A. Chitu, Bert A. van der Reijden, Aniek O. de Graaf, Arjan A. van de Loosdrecht, Joop H. Jansen

Testu osoa

Pharmacological boosting of azacitidine/venetoclax in acute myeloid leukemia nork Niels Westra, Elena Ropero Cerro, Edwin Schilder, Marjolijn N. Lub-de Hooge, Daan J. Touw, Jos G. W. Kosterink, Dana A. Chitu, Emanuele Ammatuna, Saskia K. Klein, Peter E. Westerweel, Marloes Cuijpers, Marjan Cruijsen, Maarten M. F. Corsten, Canan Alhan, Lidwine Tick, Jan Jacob Schuringa, Gerwin Huls, Carolien M. Woolthuis, Thijs H. Oude Munnink

Testu osoa

Prognostic value of measurable residual disease in high‐risk MDS after intensive chemotherapy in HOVON‐SAKK studies nork Coen R. Veenstra, Lok Lam Ngai, Patrycja Gradowska, Jurjen Versluis, Tom Reuvekamp, Angèle Kelder, Willemijn Scholten, Sander Snel, Jesse M. Tettero, Costa Bachas, Dimitri A. Breems, Thomas Fischer, Bjørn T. Gjertsen, Laimonas Griskevicius, Gunnar Juliusson, Johan A. Maertens, Markus G. Manz, Thomas Pabst, Jakob R. Passweg, Kimmo Porkka, Canan Alhan, Theresia M. Westers, David C. de Leeuw, Bob Löwenberg, Gert J. Ossenkoppele, Jacqueline Cloos, Arjan A. van de Loosdrecht

Testu osoa

Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes nork Eline M.P. Cremers, Theresia M. Westers, Canan Alhan, Claudia Cali, Heleen A. Visser-Wisselaar, Dana A. Chitu, Vincent H.J. van der Velden, Jeroen G. te Marvelde, Saskia K. Klein, Petra Muus, Edo Vellenga, Georgina E. de Greef, Marie-Cecile C.J.C. Legdeur, Pierre W. Wijermans, Marian J.P.L. Stevens-Kroef, Pedro da Silva-Coelho, Joop H. Jansen, Gert J. Ossenkoppele, Arjan A. van de Loosdrecht

Testu osoa

Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes nork Arjan A. van de Loosdrecht, Canan Alhan, Marie Christine Béné, Matteo G. Della Porta, Angelika M. Dräger, Jean Feuillard, Patricia Font, Ulrich Germing, Detlef Haase, Christa H. Homburg, Robin Ireland, Joop H. Jansen, Wolfgang Kern, Luca Malcovati, Jeroen G. te Marvelde, Ghulam J. Mufti, Kiyoyuki Ogata, Alberto Orfao, Gert J. Ossenkoppele, Anna Porwit, Frank W. Preijers, Stephen J. Richards, Gerrit Jan Schuurhuis, Dolores Subirá, Peter Valent, Vincent H.J. van der Velden, Paresh Vyas, August H. Westra, Theo M. de Witte, Denise A. Wells, Michael R. Loken, Theresia M. Westers

Testu osoa